Search clinical trials for: Endeavor drug eluting coronary stent

Total 2539 results

Henan Institute of Cardiovascular Epidemiology

Recruiting

DCB Under the Guidance of OCT in STEMI

Acute ST-segment Elevation Myocardial Infarction

China
Hospital Universitari Vall d'Hebron Research Institute
B.Braun Surgical SA

Completed

Intra-patient Study With Polymer Free Drug Eluting Stent Versus Abluminal Biodegradable Polymer Drug Eluting Stent With Early OCT (Optical Coherence Tomography) Follow up

Coronary Artery Disease

Spain
Cordis Corporation
Conor Medsystems

Completed

Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)

Coronary Disease

United States
Korea University Anam Hospital
Korea University Guro Hospital; Yonsei University; Kyungpook National University... and other collaborators

Unknown

New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial ) (Restenosis)

In-stent Arterial Restenosis

Korea, Republic of
Deutsches Herzzentrum Muenchen

Unknown

Zotarolimus and Everolimus-Eluting Stents ProsPectively Compared in Real World (ZEPPELIN)

Coronary Artery Disease

Germany
Fatebenefratelli and Ophthalmic Hospital

Completed

Drug Eluting Balloon Efficacy for Small Coronary Vessel Disease Treatment (PICCOLETO II)

Cardiovascular Diseases
Ospedale della Misericordia

Unknown

To Achieve an Early Reendothelialization at the Expense of Low Restenosis: The EREMUS Study (EREMUS)

Percutaneous Coronary Intervention | Angioplasty, Transluminal, Percutaneous Coronary

Italy
Medstar Health Research Institute

Recruiting

IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact (IMPROVE)

Atherosclerosis

United States, Sweden, Germany, Israel, Italy, United Kingdom, Greece
Beijing Tongren Hospital
First Affiliated Hospital, Sun Yat-Sen University; China-Japan Union Hospital...

Active, not recruiting

The Effects of Steroid-eluting Stent Implant for the Treatment of Eosinophilic Chronic Rhinosinusitis With Nasal Polyps

Sinusitis | Nasal Polyps | Patients

China
Shanghai Bio-heart Biological Technology Co., Ltd.
CCRF Inc., Beijing, China

Active, not recruiting

Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study

Coronary Artery Disease | Antineoplastic Agents

China
Medtronic Vascular

Completed

A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear) (Onyx ONE Clear)

Coronary Artery Disease

United States
Rigshospitalet, Denmark

Completed

Sirolimus Eluting Stents in Complex Coronary Lesions (SCANDSTENT)

Ischaemic Heart Disease

Denmark
University of Saskatchewan

Unknown

Soluble Receptors for Advanced Glycation End-Products and PCI

Acute Coronary Syndrome

Canada
Sahajanand Medical Technologies Pvt. Ltd.

Terminated

Infinnium-Core™ Registry for the Treatment of Patients With De Novo Coronary Lesions

Coronary Artery Disease

India
Raul Moreno

Completed

Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent (CIBELES)

Coronary Artery Disease | Percutaneous Coronary Intervention | Coronary Occlusion
Medinol Ltd.

Completed

PIONIR Study (Presillion™ and Presillion™ Plus Stent Systems)

Ischemic Heart Disease

Israel, Sweden, Belgium, Germany
Chang Gung Memorial Hospital

Not yet recruiting

Vascular Response of Orsiro vs. Xience Drug-Eluting Stents for Treating Coronary Bifurcation Lesions

Coronary Artery Disease

Taiwan
Seung-Jung Park
Cordis Corporation; CardioVascular Research Foundation, Korea

Terminated

Zotarolimus-Versus Sirolimus-Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients (ZEST-AMI)

Myocardial Infarction

Korea, Republic of
Boston Scientific Corporation
Labcoat, Ltd.

Completed

The Optical Coherence Tomography Drug Eluting Stent Investigation (OCTDESI)

Coronary Artery Disease

Italy
Dr Peter Barlis
Biosensors International

Unknown

Optical Coherence Tomography Assessment of Intimal Tissue and Malapposition (OPTIMA)

Coronary Heart Disease

Australia
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients (ESSENCE-DM2)

Coronary Artery Disease | Diabetes

Korea, Republic of
Medtronic Vascular

Completed

China Resolute Integrity 34/38 mm Study

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
Paul S Teirstein, MD
Cordis Corporation

Completed

The SCRIPPS DES REAL WORLD Registry

Coronary Artery Disease | Coronary Thrombosis | Coronary Restenosis

United States
University of Freiburg

Completed

Comparison of Everolimus- and Biolimus-Eluting Stents With Everolimus-Eluting Bioresorbable Vascular Scaffold Stents (EVERBIOII)

Coronary Artery Disease

Switzerland
Semmelweis University Heart and Vascular Center

Recruiting

Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis (OPEN-ISR)

Coronary Stent Restenosis

Hungary
Nanfang Hospital of Southern Medical University

Recruiting

Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis

Ischemic Stroke | Vertebral Artery Stenosis

China
Medtronic Vascular

Completed

RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia (R-A)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Coronary Stenosis

India
Universita di Verona
Regione Piemonte

Completed

Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis

Coronary Artery Disease | Atherosclerosis | Ischemic Heart Disease

Italy
Hospital Clinic of Barcelona

Completed

10-Years Follow-up of the EXAMINATION Trial (EXAMINAT10N)

Myocardial Infarction | Infarction | Necrosis | Cardiovascular Diseases | Vascular Diseases | ST Elevation Myocardial Infarction | Heart Disease

Spain, Italy, Netherlands
Yonsei University

Completed

Comparison of Biodegradable Stents: Orsiro and BioMatrix

Percutaneous Coronary Intervention | All-comer

Korea, Republic of
Sahajanand Medical Technologies Pvt. Ltd.

Completed

Supralimus-Core™ Pharmacokinetic (PK) Study

Coronary Artery Disease

India
Catholic University of the Sacred Heart

Completed

A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease

Saphenous Vein Graft Disease
Shigeru Saito
NPO International TRI Network

Terminated

Nobori And Uncoated Stent In Coronary Attack

Acute Myocardial Infarction

Japan
First Affiliated Hospital of Zhejiang University

Recruiting

Eluvia DES for the Patients With Femoropopliteal Artery Lesions.

Vascular Diseases | Stent Complication

China
Biotronik France

Unknown

BIOTRONIK - BIOFLOW-III Registry French Satellite

Coronary Artery Diseases

France
KCRI
Vascular Concepts Limited

Completed

A Clinical Evaluation of the ProNOVA XR Polymer Free Drug Eluting Coronary Stent System (EURONOVA)

Myocardial Ischemia

Poland
Broncus Technologies

Completed

Exhale (R) Stent for Emphysema

Emphysema

Germany, Australia, Brazil
Odense University Hospital

Completed

The SOURT OUT IV TRIAL (SORT OUT IV)

Ischemic Heart Disease | Percutaneous Coronary Intervention | Coronary Atherosclerosis

Denmark
Yonsei University

Withdrawn

Comparison of the 3-month Strut Coverage After Coronary Stenting by Optical Coherence Tomography; Cilotax and DESyne

Patients in the Treatment of Subjects With All-comer Who Are to Undergo PCI
Boston Scientific Corporation
Cardialysis BV

Unknown

SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries (SYNTAX)

Coronary Artery Disease

United States, Italy, Latvia, Netherlands, United Kingdom, France, Spain, Sweden, Germany, Hungary, Poland, Portugal, Austria, Belgium, Norway, Czech Republic, Denmark, Finland
Euro CTO Club
NHS Research and Development; Biosensors International; Asahi Intecc Co., Ltd.

Completed

A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions (EuroCTO)

Coronary Occlusion | Dyspnea | Chronic Stable Angina

United Kingdom, Spain, France, Germany, Italy, Latvia
Yonsei University

Unknown

Comparison of the PrimAry Long Versus Short Coverage With Drug-Eluting Stents for Long FemoRopopliteal Artery DiseasE (PARADE II): Investigator-initiated Clinical Study

Femoropopliteal Artery Disease

Korea, Republic of
Chonnam National University Hospital

Completed

Efficacy and Safety of ZotaRolimus-Eluting Coronary Stent System In Patients With Long Coronary Artery Disease

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease

Korea, Republic of
Abbott Medical Devices

Completed

The TRIMAXX Coronary Stent Trial

Coronary Artery Disease

Brazil, Germany
Medtronic Vascular

Active, not recruiting

RESOLUTE ONYX China RCT Study

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
Spanish Society of Cardiology

Completed

A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-segment Elevation Myocardial Infarction: EXAMINATION Study

Myocardial Infarction

Spain, Italy, Netherlands
Cordis Corporation

Completed

The Intra-Drug Eluting Stent (DES) Restenosis Study (CRISTAL)

Coronary Artery Disease

France
Deutsches Herzzentrum Muenchen

Unknown

Test Efficacy of Biodegradable and Permanent Limus-Eluting Stents (ISAR-TEST6)

Coronary Heart Disease

Germany
Centro de estudios en Cardiologia Intervencionista

Completed

Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents (ORAR III)

Coronary Heart Disease | Coronary Restenosis

Argentina
Sahajanand Medical Technologies Pvt. Ltd.
Cardiovascular Research Center, Brazil

Completed

The E-SERIES Registry for Supralimus® Coronary Stent for the Treatment of Unselected Patients With Coronary Lesions

Coronary Artery Disease

Brazil

Search clinical trials for: Endeavor drug eluting coronary stent

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations